|
|
Volumn 5, Issue 6 SUPPL., 2008, Pages
|
|
Pharmacotherapy for atrial arrhythmias: Present and future
|
|
Author keywords
Antiarrhythmia agent; Arrhythmia; Atrial fibrillation; Electrophysiology; Pharmacology
|
|
Indexed keywords
2' (4 METHOXYPHENYLACETAMIDOMETHYL) N [2 (3 PYRIDYL)ETHYL] 2 BIPHENYLCARBOXAMIDE;
AMIODARONE;
ANTIARRHYTHMIC AGENT;
AZIMILIDE;
BENZOFURAN DERIVATIVE;
CARDIAC AGENT;
CELIVARONE;
DOFETILIDE;
DRONEDARONE;
ION CHANNEL;
NIP 141;
NIP 142;
PLACEBO;
PROPAFENONE;
RANOLAZINE;
ROTIGAPTIDE;
SOTALOL;
SSR 149744C;
VERNAKALANT;
ARTICLE;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CREATININE BLOOD LEVEL;
DISEASE MODEL;
DISTRIBUTION VOLUME;
DRUG DESIGN;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TARGETING;
DRUG TOLERABILITY;
EXERCISE TOLERANCE;
EYE INJURY;
GAP JUNCTION;
HEART ARRHYTHMIA;
HEART ATRIUM ARRHYTHMIA;
HEART ATRIUM FIBRILLATION;
HEART PALPITATION;
HEART VENTRICLE ARRHYTHMIA;
HUMAN;
LIVER FUNCTION TEST;
LUNG TOXICITY;
MORBIDITY;
MORTALITY;
NEUROLOGIC DISEASE;
NONHUMAN;
PRIORITY JOURNAL;
QT PROLONGATION;
SIDE EFFECT;
SKIN DISEASE;
STROKE;
THYROID DISEASE;
TORSADE DES POINTES;
UNSPECIFIED SIDE EFFECT;
ANTI-ARRHYTHMIA AGENTS;
ATRIAL FIBRILLATION;
HUMANS;
|
|
EID: 43049142586
PISSN: 15475271
EISSN: None
Source Type: Journal
DOI: 10.1016/j.hrthm.2008.01.023 Document Type: Article |
|
Times cited : (19)
|
|
References (64)
|
